{"content":[{"text":"CONFIDENTIAL","bbox":{"left":0.701589,"top":0.039832,"width":0.147853,"height":0.019581}},{"text":"NATIONAL INSTITUTE FOR HEALTH AND CARE \n EXCELLENCE \n Medical technology guidance \n Assessment report overview \n The Debrisoft monofilament debridement \n pad for use in acute and chronic wounds \n This assessment report overview has been prepared by the Medical \n Technologies Evaluation Programme team to highlight the significant findings \n of the External Assessment Centre (EAC) report. It includes key features of \n the evidence base and the cost analysis, any additional analysis carried out, \n and additional information, uncertainties and key issues the Committee may \n wish to discuss. It should be read along with the sponsor’s submission of \n evidence and with the EAC report. The overview forms part of the information \n received by the Medical Technologies Advisory Committee when it develops \n its recommendations on the technology.","bbox":{"left":0.151018,"top":0.09703,"width":0.688991,"height":0.415912}},{"text":"This overview also contains:","bbox":{"left":0.151018,"top":0.532291,"width":0.25208600000000003,"height":0.01958099999999996}},{"text":" \n  \n  \n  \n ","bbox":{"left":0.151018,"top":0.573043,"width":0.009272000000000002,"height":0.11964000000000008}},{"text":"Appendix A: Sources of evidence \n Appendix B: Comments from professional bodies \n Appendix C: Comments from patient organisations \n Appendix D: External Assessment Centre correspondence \n Appendix E: Sponsor’s factual check of the assessment report and the \n External Assessment Centre’s responses","bbox":{"left":0.174797,"top":0.572051,"width":0.6272150000000001,"height":0.14517499999999994}},{"text":"Page 1 of 85 \n Assessment report overview: The Debrisoft monofilament debridement pad for use in acute \n and chronic wounds \n Date: October 2013","bbox":{"left":0.151018,"top":0.873105,"width":0.698202,"height":0.071403}}],"images_bbox":[],"images_bbox_not_text_overlap":[]}